NUCRYST Pharmaceuticals named CFO David B. Holtz as interim president and CEO of the company. Holtz will maintain his current position as CFO. He replaces Thomas E. Gardner, who was chairman, president and CEO. Neil Carragher, currently lead director of NUCRYST, will assume the role of chairman.
DATATRAK International announced that Jeffrey A. Green will step down as CEO of the company and also as a member of its board of directors to pursue other opportunities.
KineMatik Group named Michael Jarjour as president and CEO.
Abraxis BioScience has named Lex H.T. Van der Ploeg, Ph.D., as senior vice president of integrative medicine and translational science.
Champions Biotechnology appointed three key executives to the company's management team. They are: Mark Schonau as chief financial officer; Sara Parkerson, RN, MSN, OCN, CCM as director of personalized oncology services US; and Elizabeth Bruckheimer, PhD as director of preclinical development. Durwood C. Settles, who had served as acting CFO, has been named the company's controller.
MDS Pharma Services has named Rudy Howard as senior vice-president and chief financial officer.
Regado Biosciences named Steven L. Zelenkofske, D.O., F.A.C.C. to the position of senior vice president, clinical and medical affairs and chief medical officer.
Nabriva Therapeutics has appointed William Prince, Ph.D. M.D. as its chief medical officer.
Dr. Erika Nemeth has been appointed operations manager of Synexus Hungary.
IBT Laboratories has added the following people to its management team: Michael Ling, Ph.D., vice president of research and development; Christian Darabant, vice president of pharmaceutical business development; Michael Paulsen, senior director of sales; Corey Hampton, director of marketing.
Josephine Hoppe has joined Parexel as corporate vice president and chief information officer.
Jennerex announced that Samantha Miller has been appointed to the position of vice president of corporate development.
bioRASI announced that Gary W. Thompson has joined the company as vice president of business development.
NextBio has named Andrew Grygiel as vice president of marketing.
Celera named K. Scott Bland to the new position of vice president of sales at its Berkeley HeartLab.
Cyntellect has appointed Dr. Stella Redpath as director of product marketing for the company's Cell Health product line and Dr. Baggi Somasundaram as product marketing manager for the company's cell purification product line.
Cumberland Pharmaceuticals has appointed Barry Lee as product director.
Eric Van Cutsem, M.D., Ph.D., has joined the Biothera Clinical Advisory Board.
NovaBay Pharmaceuticals has appointed Harry F. Hixson, Jr., PhD to its board of directors.
BayBio elected four new executives to its board of directors for 2009. New board members for 2009 include Pierre Cassigneul, Steve Engle, John Melo and Howard Robin.
Medicago appointed Pierre Des Marais II to its board of directors.
APT Pharmaceuticals announced that Stephen Aselage has joined its board of directors.
Valeant Pharmaceuticals has appointed Anders Lonner to its board of directors.